Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2007
07/17/2007US7244818 Interferon alpha responsive protein
07/17/2007US7244814 Variant Tat proteins and methods for use thereof
07/17/2007US7244768 Side effect reduction
07/17/2007US7244743 Non-peptidic BRS-3 agonists
07/17/2007US7244721 Peptides as NS3-serine protease inhibitors of hepatitis C virus
07/17/2007US7244718 Derivatives of water insoluble drugs which exhibit good activity and water solubility; producing an anesthetic effect in a dog
07/17/2007US7244715 Vaccines containing ribavirin and methods of use thereof
07/17/2007US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders
07/17/2007US7244710 Treatment of ophthalmic infections using antimicrobial peptides
07/17/2007US7244709 comprising an aqueous mixture of parathyroid hormone, a cyclodextran and didecanoylphosphatidylcholine at concentrations sufficient to enhance permeation across the cellular layer, wherein the formulation consists of droplets, of which less than 10% are less than 10 microns in diameter
07/17/2007US7244708 Inhibitors of memapsin 2 and use thereof
07/17/2007US7244707 method to adjust the behaviour of cytotrophoblast cells of the placenta and that of stem cells by administering an effective amount of insulin-like growth factor II; treatment of pregnant women or their embryos can be used to prevent recurrent spontaneous miscarriage and pre-eclampsia
07/17/2007US7244706 For therapy of bacterial infections
07/17/2007US7244705 Polyacid glycopeptide derivatives
07/17/2007US7244704 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals
07/17/2007US7244703 Pharmaceutical compositions and methods for peptide treatment
07/17/2007US7244702 siderophores; batch affinity chromatography; for detecting antibiotic resistance
07/17/2007US7244701 For use in therapy and prophylaxis of hyponatremia, congestive heart failure, liver cirrhosis, nephrotic syndrome and hypertension
07/17/2007US7244617 Generating transgenic cell comprising expression vector coding apotosis inducing factor for use in treatment of cell proliferative and viral disorders
07/17/2007US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis
07/17/2007US7244604 HDAC9 polypeptides and polynucleotides and uses thereof
07/17/2007US7244590 Regulatory protein for Nox enzymes
07/17/2007US7244577 Method of screening for modulator of LRP5 activity
07/17/2007US7244576 Modulators of angiogenesis
07/17/2007US7244565 Gene shinc-3 and diagnostic and therapeutic uses thereof
07/17/2007US7244557 Method of screening modulators of Nod1 signaling
07/17/2007US7244437 Clostridial toxin derivatives and methods for treating pain
07/17/2007US7244436 Clostridial toxin derivatives and methods for treating pain
07/17/2007US7244428 PRO1357 antibodies
07/17/2007US7244427 Isolated bovine IgG heavy chain protein and its use as an antimicrobial
07/17/2007US7244426 Pharmaceutical compositions of fibrinolytic agent
07/17/2007US7244425 Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
07/17/2007US7244423 delivery of a neurotrophin to targeted defective, diseased or damaged cholinergic neurons
07/17/2007US7244422 Enhancing the effect of hepatitis vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration
07/17/2007US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
07/17/2007US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
07/17/2007CA2494338C Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
07/17/2007CA2305655C Self-deleting vectors for cancer therapy
07/17/2007CA2216167C Glycopeptide antibiotic derivatives
07/17/2007CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4
07/17/2007CA2145535C Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
07/17/2007CA2115348C Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes
07/17/2007CA2102594C Gene manipulation and expression using genomic elements
07/12/2007WO2007079460A2 Design of cxc chemokine analogs for the treatment of human diseases
07/12/2007WO2007079293A2 Cancer stem cells and uses thereof
07/12/2007WO2007079130A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
07/12/2007WO2007078820A2 Methylmaleimidyl polymer derivatives
07/12/2007WO2007078761A2 Method for prolonging activity of autodegradable enzymes and compositions thereof
07/12/2007WO2007078726A2 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
07/12/2007WO2007078633A2 Bacteriocin inducer peptides
07/12/2007WO2007078615A2 Methods and compositions for treatment of cancer
07/12/2007WO2007077861A1 NF-κB INHIBITOR
07/12/2007WO2007077465A2 Treatment of hiv
07/12/2007WO2007077316A1 Method for preventing and/or treating articles or media contaminated with bacteria of the legionella genus
07/12/2007WO2007077278A1 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus
07/12/2007WO2007077008A1 Chimaeric fusion protein with superior chaperone and folding activities
07/12/2007WO2007076933A1 Interleukin-12p40 variants with improved stability
07/12/2007WO2007076776A1 Method and device for vacuum drying papaya latex
07/12/2007WO2007076701A1 Extended release of neuregulin for improved cardiac function
07/12/2007WO2007076572A1 A method of treatment
07/12/2007WO2007047577A3 Use of calcitonin-related peptide (cgrp) antagonists or release inhibitors for the treatment of sleep-related breathing disorders
07/12/2007WO2007031329A3 Use of a collagen of xenogeneic origin
07/12/2007WO2007028025A3 Methods and compositions for the treatment and prevention of cholera
07/12/2007WO2007022518A3 New uses of glucoregulatory proteins
07/12/2007WO2007014254A3 Method of treating or preventing tissue deterioration, injury or damage due to hypertrophic muscle disease
07/12/2007WO2007014033A3 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure
07/12/2007WO2007012976A3 Airway administration of activated protein c in inflammatory conditions affecting the respiratory tract
07/12/2007WO2007006041A8 Imaging and therapeutic method using monocytes
07/12/2007WO2007005948A3 Methods and compositions for diagnosis and treatment of viral and bacterial infections
07/12/2007WO2007001183A3 Hecgf-1 related polymorphisms and applications thereof
07/12/2007WO2006138468A3 Use of vegf for wound healing
07/12/2007WO2006136963A3 Airway administration of site-inactivated fviia in inflammatory conditions affecting the respiratory tract
07/12/2007WO2006136962A3 Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract
07/12/2007WO2006135783A3 Compositions and methods for modulating angiogenesis
07/12/2007WO2006125201A3 Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
07/12/2007WO2006123360A3 Microspheres containing octreotide acetate
07/12/2007WO2006123256A3 Hivcon: an hiv immunogen and uses thereof
07/12/2007WO2006105199A3 Compositions and methods for synthesis of peptide and related conjugate
07/12/2007WO2006101387A3 Method for interfering with blood coagulation by modulating cross-beta structures fibril formation
07/12/2007WO2006099330A3 Compositions comprising modulators of g-protein-coupled receptor for treatment of macular degeneration
07/12/2007WO2006091795A3 METHODS AND COMPOSITIONS INVOLVING EXPRESSION OF α1C SUBUNIT OF L-TYPE CALCIUM CHANNELS IN SMOOTH MUSCLE CELLS
07/12/2007WO2006091722A3 Alkyl-glycoside enhanced vaccination
07/12/2007WO2006091610A3 Inhibitors of enveloped virus infectivity
07/12/2007WO2006084131A3 Furin inhibitors and alpha-defensins for the treatment or prevention of papillomavirus infection
07/12/2007WO2006025995A3 Compositions and methods using md-2 mutants and chimeric proteins
07/12/2007WO2006017295A3 Tetrapeptide analogs
07/12/2007WO2005097184A3 Antibodies against nogo receptor
07/12/2007WO2005077094A3 Pancreatic polypeptide family motifs and polypeptides comprising the same
07/12/2007WO2005058229A3 Antiviral proteins with improved properties and methods therefor
07/12/2007WO2005037232A3 Methods and compositions for modulating adipocyte function
07/12/2007WO2005019409A3 Combinatorial protein library screening by periplasmic expression
07/12/2007WO2004104166A3 Administration of hyaluronic acid to enhance the function of transplanted stem cells
07/12/2007US20070162994 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
07/12/2007US20070162987 Modulation of body weights; dietetics; eating disorders; for diagnostic and therapeutic implications in homeostasis of body weight and adipose tissue mass
07/12/2007US20070162984 STARS-a muscle-specific actin-binding protein
07/12/2007US20070161789 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/12/2007US20070161781 Therapeutic human albumin solutions with low prekallicrein activator (pka) activity and process for obtaining them
07/12/2007US20070161711 Process for producing pellets for pharmaceutical compositions
07/12/2007US20070161708 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
07/12/2007US20070161692 Conformationally restricted polyamine analogs as disease therapies